At Manningham Medical Centre, you can find all the data about British Medical Journal Alzheimer. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Alzheimer’s disease | The BMJ

    https://www.bmj.com/content/338/bmj.b158
    Alzheimer’s disease is a specific disease that affects about 6% of the population aged over 65 and …

Alzheimer disease - Symptoms, diagnosis and treatment

    https://bestpractice.bmj.com/topics/en-us/317
    Alzheimer disease (AD) is a chronic, progressive neurodegenerative disorder characterized by a global, nonreversible impairment in cerebral functioning. AD …

Healthy lifestyle and life expectancy with …

    https://www.bmj.com/content/377/bmj-2021-068390
    Acknowledging the influence of lifestyle on Alzheimer’s dementia (morbidity) and longevity (mortality), we used a multistate life expectancy analysis that …

Alzheimer's disease - Symptoms, diagnosis and …

    https://bestpractice.bmj.com/topics/en-gb/317
    Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder characterised by a global, non-reversible impairment in cerebral functioning. AD …

Benzodiazepine use and risk of Alzheimer’s disease: …

    https://www.bmj.com/content/349/bmj.g5205
    Objectives To investigate the relation between the risk of Alzheimer’s disease and exposure to benzodiazepines started at least five years before, considering both the …

Lecanemab for Alzheimer’s disease | The BMJ

    https://www.bmj.com/content/379/bmj.o3010
    New trial reports little to celebrate for patients and carers The detailed results of a phase 3 randomised controlled trial of lecanemab, 1 the latest monoclonal antibody …

Benzodiazepines and risk of Alzheimer’s disease | The BMJ

    https://www.bmj.com/content/349/bmj.g5312
    They observed a cumulative dose-effect association between exposure to benzodiazepines (at least 90 days) and risk of developing Alzheimer’s disease and …

Alcohol consumption and mortality in patients with mild …

    https://bmjopen.bmj.com/content/5/12/e007851
    Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study Sine Berntsen 1, Jakob Kragstrup 1, Volkert Siersma 1, Gunhild Waldemar …

Alzheimer's disease - PubMed

    https://pubmed.ncbi.nlm.nih.gov/19196745/
    Alzheimer's disease Alzheimer's disease Authors Alistair Burns 1 , Steve Iliffe Affiliation 1 University of Manchester Psychiatry Research Group, Manchester M13 …

Benzodiazepine use and risk of Alzheimer's disease: …

    https://pubmed.ncbi.nlm.nih.gov/25208536/
    Main outcome measure: The association between Alzheimer's disease and benzodiazepine use started at least five years before diagnosis was assessed by using …



Need more information about British Medical Journal Alzheimer?

At Manningham Medical Centre, we collected data on more than just British Medical Journal Alzheimer. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.